American Journal of Cardiovascular Drugs

Can Angiotensin Receptor Antagonists Prevent Restenosis After Stent Placement?
pp. 143-148(6)
Author: Peters S.

Effects of the Thiazolidinediones on Cardiovascular Risk Factors
pp. 149-156(8)
Authors: Gilling L.; Suwattee P.; DeSouza C.; Asnani S.; Fonseca V.

Cardiovascular Risk in Patients with Early Renal Insufficiency: Implications for the Use of ACE Inhibitors
pp. 157-162(6)
Authors: Mann J.F.E.; Gerstein H.C.; Pogue J.; Lonn E.; Yusuf S.

Perspectives of Drug-Eluting Stents: The Next Revolution
pp. 163-172(10)
Authors: Moses J.W.; Kipshidze N.; Leon M.B.

Naturoceutical Agents in the Management of Cardiovascular Disease
pp. 173-196(24)
Author: Hermann D.D.

Laser Coronary Angioplasty: History, Present and Future
pp. 197-207(11)
Authors: Köster R.; Kähler J.; Brockhoff C.; Münzel T.; Meinertz T.

Opinion and Evidence in Cardiovascular Therapeutics
pp. 209-217(9)